News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Maria Rescigno on ‘Microbiota in Cancer Progression and Treatment’ at EACR24
Photo from EACR/X
Jun 13, 2024, 07:40

Maria Rescigno on ‘Microbiota in Cancer Progression and Treatment’ at EACR24

EACR (European Association for Cancer Research) shared a post on X/Twitter:

”Maria Rescigno delivers the Fondazione Pezcoller – Marina Larcher Fogazzaro – EACR Women in Cancer Research Award. Lecture: ‘Microbiota in Cancer Progression and Treatment’ at EACR24.”

Source: EACR/X

cancer EACR EACR Women in Cancer Research Award EACR24 European Association for Cancer Research Fondazione Pezcoller Maria Rescigno Marina Larcher Fogazzaro OncoDaily Oncology
Blog
Jul 2, 2024, 17:41
Mukhtasar M. Alkali: Governments to prioritize Cervical Cancer Elimination affecting millions of women
Blog
Jul 2, 2024, 17:21
Amalya Sargsyan: One of Oncodaily’s top 10 promising drugs is showing great resuts at ESMOGI24
Blog
Jul 2, 2024, 17:11
Megan-Claire Chase: Serious challenges of 'surviving' breast cancer as a Black woman under 40
Blog
Jul 2, 2024, 16:22
Eric H Yang: Our talented housestaff research achievements
Blog
Jul 2, 2024, 16:08
Nelson Dusetti: Clinic and Digital Personalized Medicine seminar at the University of Corte
Blog
Jul 2, 2024, 16:00
Early registration for ASCOQLTY24 is open
Blog
Jul 2, 2024, 15:29
European Cancer Organisation - Join INTERACT EUROPE100!
Blog
Jul 2, 2024, 15:28
Sarah Louden: 2024 ASCO Direct Puerto Rico is an overwhelming success
Insight
Jul 2, 2024, 15:25
Gut microbiota associated with cancer immunotherapy outcomes
Insight
Jul 2, 2024, 15:20
Vincent Rajkumar’s 2024 update on diagnosis, risk stratification, and treatment of myeloma
Blog
Jul 2, 2024, 15:18
Rami Manochakian: 7 excellent peer-reviewed Lung Cancer articles from ASCO24 Educational Book
Insight
Jul 2, 2024, 15:14
Managing dose reduction without compromising outcomes of HR+ breast cancer